Our current finding of an association between GDNF protein levels and cognitive performance in psychosis is consistent with previous studies indicating that lower serum GDNF levels are associated with more severe cognitive deficits in first-episode schizophrenic patients and in those identified with the deficit subtype of schizophrenia (92, 93). This evidence concerns the gene GDNF and Cognitive impairment.